PARK AVENUE SECURITIES LLC
Broker-DealerPosition in TAK — Takeda Pharmaceutical Co Ltd
CIK 1071640
NEW YORK, NY
Position in TAK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$718,576
-$130,065 QoQ
Shares Held
44,827
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#116
of 375 holders
Holding Since
Dec 2020
23 quarters on record
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PARK AVENUE SECURITIES LLC holds $5,937,881 across 8 Drug Manufacturers - Specialty & Generic names. TAK ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
8,601 | $1,449,612 | |
| 2 | HLN |
Haleon plc
|
111,923 | $1,044,241 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
14,734 | $942,239 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
44,827 | $718,576 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
19,191 | $650,191 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,038 | $562,419 | |
| 7 | ZTS |
Zoetis Inc.
|
4,994 | $358,868 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
12,232 | $211,735 |
All Filings in TAK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $718,576 | 44,827 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $848,641 | 45,823 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $587,493 | 37,684 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $483,442 | 33,022 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $531,251 | 34,363 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $473,282 | 31,828 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $366,099 | 27,651 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $306,540 | 21,557 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $365,257 | 28,227 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $400,643 | 28,844 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $452,944 | 31,741 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $579,769 | 37,477 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $427,657 | 27,222 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $415,642 | 25,221 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $373,666 | 23,953 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $265,184 | 20,446 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $270,255 | 19,249 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $222,547 | 15,541 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $172,392 | 12,648 | Shares | Sole | 2022-04-08 | |
| 2021-09-30 | $202,587 | 12,368 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $213,808 | 12,704 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $225,693 | 12,360 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $196,942 | 10,821 | Shares | Sole | 2021-01-20 | |
| No filing history on record for this holder in this stock. | ||||||